Stocktoria
Bicara Therapeutics Inc. BCAX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-09-13
Bicara Therapeutics Inc. statistics & valuation
Market cap$1.8B
P / B4.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Return on assets | -32.0% | -13.3% | -22.2% |
| Return on equity | -34.4% | -13.8% | 34.9% |
| Current ratio | 14.58 | 27.93 | 15.32 |
Source: SEC EDGAR filings · CIK 0002023658 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.